CUSIP G4444C102COMMLTXQ3 2025
14 filings · latest Feb 15, 2024
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Decheng Capital LLC | 181.6K | $1.30M |
| 4 | Feb 14, 2022 | Citadel Advisors LLC | 13G/A | 5.7% | — | SEC |
| 5 | Feb 14, 2022 | Price T Rowe Associates Inc /Md/ | 13G/A | 6.2% | 746.9K | SEC |
| 6 | Dec 10, 2021 | Fmr LLC | 13G | 10.0% | — | SEC |
| 7 | Nov 15, 2021 | Ra Capital Management, L.P. | 13G/A | — | — | SEC |
| 8 | Feb 16, 2021 | Rtw Investments, LP | 13G | 6.3% | 750.0K | SEC |
| 9 | Feb 16, 2021 | Ra Capital Management, L.P. | 13G | 5.9% | 700.0K | SEC |
| 10 | Feb 16, 2021 | Citadel Advisors LLC | 13G/A | 5.7% | — | SEC |
See the full Schedule 13D/13G history for Moonlake Immunotherapeutics.
Unlock full history